Company news
Adhera Therapeutics Inc. news in 2016
Adhera Therapeutics Inc.'s news releases, calls and decks from 2016, newest first.
Marina Biotech to Update Its tkRNAi Clinical Program at Biotech Showcase
December 27, 2016
Philippe P. Calais to Join Marina Biotech's Board of Directors
December 14, 2016
Marina Biotech to Present at the 9th Annual LD Micro Main Event
November 25, 2016
Marina Biotech Announces Merger with IthenaPharma
November 16, 2016
Marina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French
June 2, 2016
Marina Biotech to Acquire Late-Stage Program From Turing Pharmaceuticals
May 3, 2016
Marina Biotech Terminates Negotiations for Sale of Its Nucleic Acid Therapeutic Assets
May 3, 2016
Marina Biotech Provides 2015 Year-End Financials and Update
March 31, 2016
Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology
March 16, 2016
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
March 15, 2016
Marina Biotech Announces Evaluation and Option Agreement to Deliver a Genome Editing Technology
February 18, 2016
Marina Biotech to Explore Strategic Alternatives
February 17, 2016
Decks in 2016
- Marina Biotech — LD Micro Main Event 2016
Conference · 20 slides · Dec 8, 2016